510(k) Report

510(k) · Cleared

Cleared

Cabochon System

K134010510(k) TraditionalCleared Apr 14, 2014105-day reviewClass II21 CFR 878.4790

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cabochon Aesthetics, Inc. · OUP Powered Surgical Instrument For Improvement In The Appearance Of Cellulite

Cleared on Apr 14, 2014 as substantially equivalent to DEN110004 (Cabochon Aesthetics, Inc., 2013) after a 105-day review. Its family tree reaches back 1 generation to 2013. 7 later devices descend from it.

Decided
Apr 14, 2014
Review
105 days
Class
Class II
Product code
OUP
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN110004 (2013). 7 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2015: 1 descendant cleared2016: 2 descendants cleared2019: 1 descendant cleared2021: 1 descendant cleared2022: 1 descendant cleared2023: 1 descendant clearedDEN110004 · Cabochon System · Cabochon Aesthetics, Inc. · 20132010201520202025
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant3 generations forward: 1 descendant4 generations forward: 1 descendant5 generations forward: 1 descendant6 generations forward: 1 descendant7 generations forward: 1 descendant DEN110004 · Cabochon System · Cabochon Aesthetics, Inc. · 20130+5
  1. Root · 1 generation backDEN110004 Cabochon SystemCabochon Aesthetics, Inc. · 2013
  2. This deviceK134010 Cabochon SystemCabochon Aesthetics, Inc. · 2014
  3. Descendant · cites it directly · 6 of its ownK150505 Cellfina SystemUlthera, Inc. · 2015
  4. Descendant · 2 generations on · 5 of its ownK153677 The Cellfina SystemUlthera, Inc. · 2016
  5. Descendant · 3 generations on · 4 of its ownK161885 The Cellfina SystemUlthera, Inc. · 2016 · Recalled
  6. Descendant · 4 generations on · 3 of its ownK192185 The Cellfina SystemUlthera, Inc. · 2019
  7. Descendant · 5 generations on · 2 of its ownK212399 AveliNc8, Inc. · 2021

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2015: 12016: 22019: 12021: 12022: 12023: 1
2015high 2 (2016) · low 0 (2017)2026

Most influential descendants

Showing 5 of 7 · See all
  • K150505Cellfina SystemUlthera, Inc. · 2015 · cites it directly6descendants
  • K153677The Cellfina SystemUlthera, Inc. · 2016 · 2 generations on5descendants
  • K161885The Cellfina SystemUlthera, Inc. · 2016 · 3 generations on4descendants
  • K192185The Cellfina SystemUlthera, Inc. · 2019 · 4 generations on3descendants
  • K212399AveliNc8, Inc. · 2021 · 5 generations on2descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN110004Cabochon SystemCabochon Aesthetics, Inc.2013—
0 (this device)K134010Cabochon SystemCabochon Aesthetics, Inc.2014—
+1K150505Cellfina SystemUlthera, Inc.2015—
+2K153677The Cellfina SystemUlthera, Inc.2016—
+3K161885The Cellfina SystemUlthera, Inc.20161
+4K192185The Cellfina SystemUlthera, Inc.2019—
+5K212399AveliNc8, Inc.2021—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201510
201620
201910
202110
202210
202310
FIG. 1 — Lineage of K134010, 2013–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OUP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OUP device

  1. #1 K221336 Avéliscore 8.6 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN110004Cabochon System
Our reading of the summary gave K101231, which is not in FDA’s 510(k) list. The device the summary names is FDA’s De Novo DEN110004, Cabochon System (Cabochon Aesthetics, Inc.), granted Jul 12, 2013; older De Novo requests were first filed under a 510(k) number, so this links to the grant.
Cabochon Aesthetics, Inc.2013—

What descends from it? (7)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K150505Cellfina SystemUlthera, Inc.20156

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K150505 (Ulthera, Inc., 2015) has gone furthest, with 6 descendants of its own.

How does its category compare?

All OUP devices

OUP Powered Surgical Instrument For Improvement In The Appearance Of Cellulite: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · OUP

1in 2023

2013: 12014: 12015: 12016: 22019: 12021: 12022: 12023: 1
2007high 2 (2016) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OUP

Too few OUP 510(k)s in any year since 2007 to give a median.

Recalls per year · OUP

1in 2016

2016: 1
2007high 1 (2016) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OUP

4in 2025

2016: 32017: 42018: 82019: 162020: 32021: 92022: 152023: 112024: 62025: 4
2007high 16 (2019) · low 0 (2007)2025

MAUDE reports naming product code OUP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20131—00
20141—00
20151—00
20162—13
20170—04
20180—08
20191—016
20200—03
20211—09
20221—015
20231—011
20240—06
20250—04
20260—0—

What is it indicated for?

The Cabochon System is intended for long term improvement in the appearance of cellulite in the buttocks and thigh areas of adult females as supported by clinical data demonstrating no significant reduction in treatment benefits up to 1 year of observation.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K134010: Cabochon System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K134010

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026